ARTICLE | Clinical News
Corifollitropin alfa regulatory update
September 16, 2013 7:00 AM UTC
FDA accepted for review an NDA from Merck for corifollitropin alfa for controlled ovarian stimulation to treat infertility in women participating in assisted reproductive technology (ART). The PDUFA d...